Amsterdam, The Netherlands, and Holzgerlingen, Germany, July 01, 2020, 08:30 am CEST - Curetis N.V. in liquidatie (the "Company") today announced...
Amsterdam, The Netherlands, and Holzgerlingen, Germany, April 30, 2020, 08:00 am CET - Curetis N.V. in liquidatie (the "Company") today announced...
Amsterdam, the Netherlands, Holzgerlingen, Germany April 20, 2020, 8:00 am CEST - Curetis N.V. in liquidatie (the "Company") announces that the...
- Following approval of shareholders, companies sign German transfer agreement - Curetis GmbH and its subsidiaries Curetis USA Inc. and Ares...
Quorum achieved for OpGen stockholder vote on Curetis business combination with 99% of votes supporting transactionTransaction close anticipated...
, a developer of next-level molecular diagnostic solutions, today announced that it starts offering a CE-IVD certified real-time PCR test kit for...
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, March 10, 2020, 16:15 pm CET - Curetis N.V. (the "Company" and...
- Shareholders adopt all proposed resolutions - EGM votes clear way for closing of business combination with...
Revenue increases by 64% to EUR 2.3 million, up from 1.4 million in 2018More than tripled...
Exclusive distribution agreement for initial term of 3 yearsQuaphaco commits to minimum purchase totaling about EUR 1.9 million during initial...
BGI Group responds to coronavirus crisis by providing reagent kits for molecular 2019-nCoV testing by next-generation sequencing and RT-PCRAres...
Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, January 27, 2020, 08:00 am CET / 02:00 am EDT - Curetis N.V. (the...
Amsterdam, the Netherlands, and Holzgerlingen, Germany, January 23, 2020, 10:00 am CET - Curetis N.V. (the "Company" and, together with its...
Panel also includes atypical pathogens such as Pneumocystis jiroveciiLRT BAL Panel expected to substantially increase total addressable market...
Broad Unyvero LRT BAL panel also includes atypical pathogens such as Pneumocystis jiroveciiClearance expected to substantially increase total...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads